Kiadis Pharma announces formation of renowned Scientific Advisory Board
22 oct. 2019 01h00 HE
|
Kiadis Pharma N.V.
Amsterdam, The Netherlands, 22 October 2019 – Kiadis Pharma N.V. (“Kiadis Pharma” or the “Company”) (Euronext Amsterdam and Brussels: KDS), a clinical stage biopharmaceutical company, today announces...
Kiadis Pharma provides regulatory update on ATIR101
17 oct. 2019 11h50 HE
|
Kiadis Pharma N.V.
Kiadis no longer expects EU conditional marketing authorization for ATIR101 in 2020Kiadis plans to refile at the conclusion of the ongoing phase 3 trial Amsterdam, The Netherlands, 17 October 2019 –...
Kiadis Pharma announces results for the six months ended June 30, 2019
10 sept. 2019 01h00 HE
|
Kiadis Pharma N.V.
Kiadis to hold conference call with investors today at 15:00 CEST Amsterdam, The Netherlands, September 10, 2019 – Kiadis Pharma N.V. (“Kiadis Pharma” or the “Company”) (Euronext Amsterdam and...
Kiadis Pharma Announces Investor Events for September 2019
19 août 2019 11h45 HE
|
Kiadis Pharma N.V.
Company announces Notice of Results for the six months ended June 30, 2019 Amsterdam, The Netherlands, August 19, 2019 – Kiadis Pharma N.V. (“Kiadis Pharma” or the “Company”) (Euronext Amsterdam...
Kiadis Pharma to present at upcoming conference in August 2019
31 juil. 2019 11h45 HE
|
Kiadis Pharma N.V.
Kiadis Pharma to present at upcoming conference in August 2019 Amsterdam, The Netherlands, July 31, 2019 – Kiadis Pharma N.V. (“Kiadis Pharma” or the “Company”) (Euronext Amsterdam and Brussels:...
Kiadis Pharma Announces Results Annual General Meeting
24 juin 2019 11h50 HE
|
Kiadis Pharma Netherlands B.V.
Kiadis Pharma Announces Results Annual General Meeting Amsterdam, The Netherlands, June 24, 2019 - Kiadis Pharma N.V. ("Kiadis Pharma" or the "Company") (Euronext Amsterdam and Brussels:...
Kiadis Pharma completes acquisition of CytoSen Therapeutics, Inc.
06 juin 2019 01h30 HE
|
Kiadis Pharma Netherlands B.V.
Amsterdam, The Netherlands, June 6, 2019 - Kiadis Pharma N.V. ("Kiadis" or the "Company") (Euronext Amsterdam and Brussels: KDS), a clinical stage biopharmaceutical company, today announces that it...
Kiadis Pharma to present at upcoming conferences in June 2019
03 juin 2019 11h45 HE
|
Kiadis Pharma Netherlands B.V.
Kiadis Pharma to present at upcoming conferences in June 2019 Amsterdam, The Netherlands, June 3, 2019 - Kiadis Pharma N.V. ("Kiadis Pharma" or...
Kiadis Pharma raises c.EUR 28 million in a private placement of c.3.7 million new shares
31 mai 2019 02h00 HE
|
Kiadis Pharma Netherlands B.V.
Not for release, publication or distribution, directly or indirectly, in or into the United States, Australia, Canada, Japan, south africa or Any other jurisdiction in which such release,...
Kiadis Pharma launches a private placement of new shares to raise approximately EUR 25 million
30 mai 2019 11h45 HE
|
Kiadis Pharma Netherlands B.V.
Not for release, publication or distribution, directly or indirectly, in or into the United States, Australia, Canada, Japan, south africa or Any other jurisdiction in which such release,...